TradeSingle-source
2.1
Zentiva Bucharest facility achieves cost parity with Indian pharmaceutical manufacturing
Ziarul FinanciarLO·RO · DE · FR·3 days ago
The head of Boehringer Ingelheim's regional branch warns that Europe's lagging research investment compared to the US and China threatens the timely availability of essential medications. The statement highlights structural concerns regarding European pharmaceutical competitiveness and supply chain resilience.
Entities